合寶丰年(08406.HK)前三季度純利升41.14%至1194.9萬元
格隆匯11月8日丨合寶丰年(08406.HK)公佈,截至2019年9月30日止9個月,公司實現收入1.53億元人民幣(下同),同比增長32.18%;毛利3444.4萬元,同比增長33.18%;公司擁有人應占盈利1194.9萬元,同比增長41.14%;基本每股盈利1.49分;不派息。
於期內,來自銷售帶鼓風機的充氣遊樂產品的收入為約1.36億元,同比增長33.3%,佔總收入約89.0%;來自銷售其他充氣產品的收入為約300.5萬元,同比增長0.7%,佔總收入約2.0%;來自銷售充氣產品相關附屬品及分包工作的收入為約1375.9萬元,同比增長30.4%,佔總收入約9.0%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.